
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
VDUP1 CRISPR/Cas9 KO Plasmid (m) | sc-425098 | 20 µg | $397.00 |
Txnip encodes thioredoxin-interacting protein (VDUP1), a redox-regulatory factor that binds and inhibits thioredoxin, thereby shaping cellular oxidative stress responses and redox-sensitive signaling. In mouse cells, VDUP1 influences glucose and lipid metabolism, mitochondrial function, and inflammatory programs, with reported connections to AMPK/mTOR signaling and modulation of NLRP3 inflammasome activity. Altered Txnip expression has been associated with metabolic stress phenotypes and dysregulated immune signaling, making it a useful node for studying how redox control interfaces with nutrient sensing and cytokine pathways. Because Txnip is transcriptionally responsive to glucose, ER stress, and oxidative cues, it is frequently examined in models of metabolic dysfunction and inflammation-related tissue injury.
VDUP1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Txnip gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Txnip together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Txnip open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish VDUP1 protein expression.
This CRISPR knockout system enables efficient generation of Txnip-deficient cell models for investigation of VDUP1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.